PTEN deficiency: a role in mammary carcinogenesis
10.1186/bcr322
Crossref journal-article
Springer Science and Business Media LLC
Breast Cancer Research (297)
Bibliography

Petrocelli, T., & Slingerland, J. M. (2001). PTEN deficiency: a role in mammary carcinogenesis. Breast Cancer Research, 3(6).

Authors 2
  1. Teresa Petrocelli (first)
  2. Joyce M Slingerland (additional)
References 46 Referenced 32
  1. Li Y, Podsypanina K, Liu X, Crane A, Tan LK, Parsons R, Varmus HE: Deficiency of Pten accelerates mammary oncogenesis in MMTV-Wnt-1 transgenic mice. BMC Mol Biol. 2001, 2: 2-10. 10.1186/1471-2199-2-2. (10.1186/1471-2199-2-2) / BMC Mol Biol by Y Li (2001)
  2. Hanahan D, Weinberg RA: The hallmarks of cancer. Cel. 2000, 100: 57-70. 10.1016/S0092-8674(00)81683-9. (10.1016/S0092-8674(00)81683-9) / Cel by D Hanahan (2000)
  3. Nusse R, Varmus HE: Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. Cell. 1982, 31: 99-109. (10.1016/0092-8674(82)90409-3) / Cell by R Nusse (1982)
  4. Tsukamoto AS, Grosschedl R, Guzman RC, Parslow T, Varmus HE: Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice. Cell. 1988, 55: 619-625. (10.1016/0092-8674(88)90220-6) / Cell by AS Tsukamoto (1988)
  5. Morin PJ: Beta-catenin signaling and cancer. Bioessays. 1999, 21: 1021-1030. 10.1002/(SICI)1521-1878(199912)22:1<1021::AID-BIES6>3.3.CO;2-G. (10.1002/(SICI)1521-1878(199912)22:1<1021::AID-BIES6>3.0.CO;2-P) / Bioessays by PJ Morin (1999)
  6. Imbert A, Eelkema R, Jordan S, Feiner H, Cowin P: Delta N89 beta-catenin induces precocious development, differentiation, and neoplasia in mammary gland. J Cell Biol. 2001, 153: 555-568. 10.1083/jcb.153.3.555. (10.1083/jcb.153.3.555) / J Cell Biol by A Imbert (2001)
  7. Simpson L, Parsons R: PTEN: life as a tumor suppressor. Exp Cell Res. 2001, 264: 29-41. 10.1006/excr.2000.5130. (10.1006/excr.2000.5130) / Exp Cell Res by L Simpson (2001)
  8. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh H, Wigler MH, Parsons R: PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science. 1997, 275: 1943-1947. 10.1126/science.275.5308.1943. (10.1126/science.275.5308.1943) / Science by J Li (1997)
  9. Steck PA, Pershouse MA, Jasser SA, Yung WK, Lin H, Ligon AH, Langford LA, Baumgard ML, Hattier T, Davis T, Frye C, Hu R, Swedlund B, Teng DH, Tavtigian SV: Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet. 1997, 15: 356-362. (10.1038/ng0497-356) / Nat Genet by PA Steck (1997)
  10. Liaw D, Marsh DJ, Li J, Dahia PL, Wang SI, Zheng Z, Bose S, Call KM, Tsou HC, Peacocke M, Eng C, Parsons R: Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet. 1997, 16: 64-67. (10.1038/ng0597-64) / Nat Genet by D Liaw (1997)
  11. Marsh DJ, Coulon V, Lunetta KL, Rocca-Serra P, Dahia PL, Zheng Z, Liaw D, Caron S, Duboue B, Lin AY, Richardson AL, Bonnetblanc JM, Bressieux JM, Cabarrot-Moreau A, Chompret A, Demange L, Eeles RA, Yahanda AM, Fearon ER, Fricker JP, Gorlin RJ, Hodgson SV, Huson S, Lacombe D, Eng C: Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation. Hum Mol Genet. 1998, 7: 507-515. 10.1093/hmg/7.3.507. (10.1093/hmg/7.3.507) / Hum Mol Genet by DJ Marsh (1998)
  12. Schrager CA, Schneider D, Gruener AC, Tsou HC, Peacocke M: Clinical and pathological features of breast disease in Cowden's syndrome: an underrecognized syndrome with an increased risk of breast cancer. Hum Pathol. 1998, 29: 47-53. (10.1016/S0046-8177(98)90389-6) / Hum Pathol by CA Schrager (1998)
  13. Fackenthal JD, Marsh DJ, Richardson AL, Cummings SA, Eng C, Robinson BG, Olopade OI: Male breast cancer in Cowden syndrome patients with germline PTEN mutations. J Med Genet. 2001, 38: 159-164. 10.1136/jmg.38.3.159. (10.1136/jmg.38.3.159) / J Med Genet by JD Fackenthal (2001)
  14. Kong D, Suzuki A, Zou TT, Sakurada A, Kemp LW, Wakatsuki S, Yokoyama T, Yamakawa H, Furukawa T, Sato M, Ohuchi N, Sato S, Yin J, Wang S, Abraham JM, Souza RF, Smolinski KN, Meltzer SJ, Horii A: PTEN1 is frequently mutated in primary endometrial carcinomas. Nat Genet. 1997, 17: 143-144. (10.1038/ng1097-143) / Nat Genet by D Kong (1997)
  15. Wang SI, Puc J, Li J, Bruce JN, Cairns P, Sidransky D, Parsons R: Somatic mutations of PTEN in glioblastoma multiforme. Cancer Res. 1997, 57: 4183-4186. / Cancer Res by SI Wang (1997)
  16. Tsao H, Zhang X, Benoit E, Haluska FG: Identification of PTEN/MMAC1 alterations in uncultured melanomas and melanoma cell lines. Oncogene. 1998, 16: 3397-3402. 10.1038/sj/onc/1201881. (10.1038/sj.onc.1201881) / Oncogene by H Tsao (1998)
  17. Maehama T, Dixon JE: The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem. 1998, 273: 13375-13378. 10.1074/jbc.273.22.13375. (10.1074/jbc.273.22.13375) / J Biol Chem by T Maehama (1998)
  18. Downward J: Mechanisms and consequences of activation of protein kinase B/Akt. Curr Opin Cell Biol. 1998, 10: 262-267. 10.1016/S0955-0674(98)80149-X. (10.1016/S0955-0674(98)80149-X) / Curr Opin Cell Biol by J Downward (1998)
  19. Mirza AM, Kohn AD, Roth RA, McMahon M: Oncogenic transformation of cells by a conditionally active form of the protein kinase Akt/PKB. Cell Growth Differ. 2000, 11: 279-292. / Cell Growth Differ by AM Mirza (2000)
  20. Singh B, Ittmann MM, Krolewski JJ: Sporadic breast cancers exhibit loss of heterozygosity on chromosome segment 10q23 close to the Cowden disease locus. Genes Chromosomes Cancer. 1998, 21: 166-171. 10.1002/(SICI)1098-2264(199802)21:2<166::AID-GCC13>3.3.CO;2-V. (10.1002/(SICI)1098-2264(199802)21:2<166::AID-GCC13>3.0.CO;2-P) / Genes Chromosomes Cancer by B Singh (1998)
  21. Bose S, Wang SI, Terry MB, Hibshoosh H, Parsons R: Allelic loss of chromosome 10q23 is associated with tumor progression in breast carcinomas. Oncogene. 1998, 17: 123-127. 10.1038/sj/onc/1201940. (10.1038/sj.onc.1201940) / Oncogene by S Bose (1998)
  22. Chen ST, Yu SY, Tsai M, Yeh KT, Wang JC, Kao MC, Shih MC, Chang JG: Mutation analysis of the putative tumor suppression gene PTEN/MMAC1 in sporadic breast cancer. Breast Cancer Res Treat. 1999, 55: 85-89. 10.1023/A:1006142919428. (10.1023/A:1006142919428) / Breast Cancer Res Treat by ST Chen (1999)
  23. Freihoff D, Kempe A, Beste B, Wappenschmidt B, Kreyer E, Hayashi Y, Meindl A, Krebs D, Wiestler OD, von Deimling A, Schmutzler RK: Exclusion of a major role for the PTEN tumour-suppressor gene in breast carcinomas. Br J Cancer. 1999, 79: 754-758. 10.1038/sj.bjc.6690121. (10.1038/sj.bjc.6690121) / Br J Cancer by D Freihoff (1999)
  24. Feilotter HE, Coulon V, McVeigh JL, Boag AH, Dorion-Bonnet F, Duboue B, Latham WC, Eng C, Mulligan LM, Longy M: Analysis of the 10q23 chromosomal region and the PTEN gene in human sporadic breast carcinoma. Br J Cancer. 1999, 79: 718-723. 10.1038/sj.bjc.6690115. (10.1038/sj.bjc.6690115) / Br J Cancer by HE Feilotter (1999)
  25. Ueda K, Nishijima M, Inui H, Watatani M, Yayoi E, Okamura J, Yasutomi M, Nakamura Y, Miyoshi Y: Infrequent mutations in the PTEN/MMAC1 gene among primary breast cancers. Jpn J Cancer Res. 1998, 89: 17-21. (10.1111/j.1349-7006.1998.tb00473.x) / Jpn J Cancer Res by K Ueda (1998)
  26. Rhei E, Kang L, Bogomolniy F, Federici MG, Borgen PI, Boyd J: Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas. Cancer Res. 1997, 57: 3657-3659. / Cancer Res by E Rhei (1997)
  27. Perren A, Weng LP, Boag AH, Ziebold U, Thakore K, Dahia PL, Komminoth P, Lees JA, Mulligan LM, Mutter GL, Eng C: Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomas of the breast. Am J Pathol. 1999, 155: 1253-1260. (10.1016/S0002-9440(10)65227-3) / Am J Pathol by A Perren (1999)
  28. Di Cristofano A, Pesce B, Cordon-Cardo C, Pandolfi PP: Pten is essential for embryonic development and tumour suppression. Nat Genet. 1998, 19: 348-355. 10.1038/1235. (10.1038/1235) / Nat Genet by A Di Cristofano (1998)
  29. Suzuki A, de la Pompa JL, Stambolic V, Elia AJ, Sasaki T, del Barco Barrantes I, Ho A, Wakeham A, Itie A, Khoo W, Fukumoto M, Mak TW: High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice. Curr Biol. 1998, 8: 1169-1178. 10.1016/S0960-9822(07)00488-5. (10.1016/S0960-9822(07)00488-5) / Curr Biol by A Suzuki (1998)
  30. Podsypanina K, Ellenson LH, Nemes A, Gu J, Tamura M, Yamada KM, Cordon-Cardo C, Catoretti G, Fisher PE, Parsons R: Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems. Proc Natl Acad Sci USA. 1999, 96: 1563-1568. 10.1073/pnas.96.4.1563. (10.1073/pnas.96.4.1563) / Proc Natl Acad Sci USA by K Podsypanina (1999)
  31. Stambolic V, Tsao MS, Macpherson D, Suzuki A, Chapman WB, Mak TW: High incidence of breast and endometrial neoplasia resembling human Cowden syndrome in pten+/- mice. Cancer Res. 2000, 60: 3605-3611. / Cancer Res by V Stambolic (2000)
  32. Harwood AJ: Regulation of GSK-3: a cellular multiprocessor. Cell. 2001, 105: 821-824. 10.1016/S0092-8674(01)00412-3. (10.1016/S0092-8674(01)00412-3) / Cell by AJ Harwood (2001)
  33. Diehl JA, Cheng M, Roussel MF, Sherr CJ: Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev. 1998, 12: 3499-3511. (10.1101/gad.12.22.3499) / Genes Dev by JA Diehl (1998)
  34. Rimerman RA, Gellert-Randleman A, Diehl JA: Wnt1 and MEK1 cooperate to promote cyclin D1 accumulation and cellular transformation. J Biol Chem. 2000, 275: 14736-14742. 10.1074/jbc.M910241199. (10.1074/jbc.M910241199) / J Biol Chem by RA Rimerman (2000)
  35. Persad S, Attwell S, Gray V, Delcommenne M, Troussard A, Sanghera J, Dedhar S: Inhibition of integrin-linked kinase (ILK) suppresses activation of protein kinase B/Akt and induces cell cycle arrest and apoptosis of PTEN-mutant prostate cancer cells. Proc Natl Assoc Sci USA. 2000, 97: 3207-3212. 10.1073/pnas.060579697. (10.1073/pnas.97.7.3207) / Proc Natl Assoc Sci USA by S Persad (2000)
  36. Persad S, Troussard AA, McPhee TR, Mulholland DJ, Dedhar S: Tumor suppressor PTEN inhibits nuclear accumulation of beta-catenin and T cell/lymphoid enhancer factor 1-mediated transcriptional activation. J Cell Biol. 2001, 153: 1161-1174. 10.1083/jcb.153.6.1161. (10.1083/jcb.153.6.1161) / J Cell Biol by S Persad (2001)
  37. Delcommenne M, Tan C, Gray V, Rue L, Woodgett J, Dedhar S: Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase. Proc Natl Assoc Sci USA. 1998, 95: 11211-11216. 10.1073/pnas.95.19.11211. (10.1073/pnas.95.19.11211) / Proc Natl Assoc Sci USA by M Delcommenne (1998)
  38. Persad S, Attwell S, Gray V, Mawji N, Deng JT, Leung D, Yan J, Sanghera J, Walsh MP, Dedhar S: Regulation of protein kinase B/Akt-serine 473 phosphorylation by integrin-linked kinase: critical roles for kinase activity and amino acids arginine 211 and serine 343. J Biol Chem. 2001, 276: 27462-27469. 10.1074/jbc.M102940200. (10.1074/jbc.M102940200) / J Biol Chem by S Persad (2001)
  39. Hutchinson J, Jin J, Cardiff RD, Woodgett JR, Muller WJ: Activation of Akt (protein kinase B) in mammary epithelium provides a critical cell survival signal required for tumor progression. Mol Cell Biol. 2001, 21: 2203-2212. 10.1128/MCB.21.6.2203-2212.2001. (10.1128/MCB.21.6.2203-2212.2001) / Mol Cell Biol by J Hutchinson (2001)
  40. Li DM, Sun H: PTEN/MMAC1/TEP1 suppresses the tumorigenicity and induces G1 cell cycle arrest in human glioblastoma cells. Proc Natl Acad Sci USA. 1998, 95: 15406-15411. 10.1073/pnas.95.26.15406. (10.1073/pnas.95.26.15406) / Proc Natl Acad Sci USA by DM Li (1998)
  41. Cheney IW, Neuteboom ST, Vaillancourt MT, Ramachandra M, Bookstein R: Adenovirus-mediated gene transfer of MMAC1/PTEN to glioblastoma cells inhibits S phase entry by the recruitment of p27Kip1 into cyclin E/CDK2 complexes. Cancer Res. 1999, 59: 2318-2323. / Cancer Res by IW Cheney (1999)
  42. Ignatoski KM, Maehama T, Markwart SM, Dixon JE, Livant DL, Ethier SP: ERBB-2 overexpression confers PI 3' kinase-dependent invasion capacity on human mammary epithelial cells. Br J Cancer. 2000, 82: 666-674. 10.1054/bjoc.1999.0979. (10.1054/bjoc.1999.0979) / Br J Cancer by KM Ignatoski (2000)
  43. Tamura M, Gu J, Matsumoto K, Aota S, Parsons R, Yamada KM: Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science. 1998, 280: 1614-1617. 10.1126/science.280.5369.1614. (10.1126/science.280.5369.1614) / Science by M Tamura (1998)
  44. Jiang BH, Zheng JZ, Aoki M, Vogt PK: Phosphatidylinositol 3-kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells. Proc Natl Acad Sci USA. 2000, 97: 1749-1753. 10.1073/pnas.040560897. (10.1073/pnas.040560897) / Proc Natl Acad Sci USA by BH Jiang (2000)
  45. Wen S, Stolarov J, Myers MP, Su JD, Wigler MH, Tonks NK, Durden DL: PTEN controls tumor-induced angiogenesis. Proc Natl Acad Sci USA. 2001, 98: 4622-4627. 10.1073/pnas.081063798. (10.1073/pnas.081063798) / Proc Natl Acad Sci USA by S Wen (2001)
  46. Hidalgo M, Rowinsky EK: The rapamycin-sensitive signal transduction pathway as a target for cancer therapy. Oncogene. 2000, 19: 6680-6686. 10.1038/sj/onc/1204091. (10.1038/sj.onc.1204091) / Oncogene by M Hidalgo (2000)
Dates
Type When
Created 22 years, 10 months ago (Sept. 26, 2002, 4:07 a.m.)
Deposited 8 years, 7 months ago (Jan. 18, 2017, 1:26 a.m.)
Indexed 3 months ago (May 19, 2025, 4:46 a.m.)
Issued 23 years, 8 months ago (Dec. 1, 2001)
Published 23 years, 8 months ago (Dec. 1, 2001)
Published Online 23 years, 8 months ago (Dec. 1, 2001)
Published Print 23 years, 8 months ago (Dec. 1, 2001)
Funders 0

None

@article{Petrocelli_2001, title={PTEN deficiency: a role in mammary carcinogenesis}, volume={3}, ISSN={1465-542X}, url={http://dx.doi.org/10.1186/bcr322}, DOI={10.1186/bcr322}, number={6}, journal={Breast Cancer Research}, publisher={Springer Science and Business Media LLC}, author={Petrocelli, Teresa and Slingerland, Joyce M}, year={2001}, month=dec }